1. Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
   Sebastian Chrétien et al, 2019, Cancers CrossRef
2. Single-nucleotide polymorphisms (SNPs) of antioxidant enzymes SOD2 and GSTP1 genes and SLE risk and severity in an Egyptian pediatric population
   Rania A. Abd El Azeem et al, 2021, Clinical Biochemistry CrossRef
3. Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 κB-p53-caspase-3 pathways modulation
   Marwa A. Mahmoud et al, 2021, Journal of Applied Biomedicine CrossRef
4. The role of TLRs in cervical cancer with HPV infection: a review
   Xiao Yang et al, 2017, Signal Transduction and Targeted Therapy CrossRef
5. Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women
   Magdy M. Youssef et al, 2021, Biochemical Genetics CrossRef
6. Chemoresistance mechanisms of breast cancer and their countermeasures
   Xiwei Ji et al, 2019, Biomedicine & Pharmacotherapy CrossRef
7. Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment
   Md Abdus Subhan, 2023, Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach CrossRef
8. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
   Shivam Singh et al, 2023, Frontiers in Oncology CrossRef
9. -196 to -174del, rs4696480, rs3804099 polymorphisms of Toll-like receptor 2 gene impact the susceptibility of cancers: evidence from 37053 subjects
   Sheng-Lin Gao et al, 2019, Bioscience Reports CrossRef
10. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma
    Xin-Bin Pan et al, 2019, Aging CrossRef
11. Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression
    Macherki Yosra et al, 2019, Journal of Immunology Research CrossRef